Mitotherapeutix
WebMitotherapeutix was created to take advantage of advancements in RNA chemistry and its use in developing new drugs (siRNA) which can target “undruggable” disease targets. … WebThe domain Mitotherapeutix.com was registered 3 years ago. The website is currently online. It is ranked n/a in the world . Here are more than n/a visitors and the pages are …
Mitotherapeutix
Did you know?
Web24 sep. 2024 · FARMINGTON, Conn., Sept. 24, 2024 /PRNewswire-PRWeb/ -- Mitotherapeutix LLC (MITO), a pre-clinical stage company focused on siRNA drug discovery and development based on suppression of the ... WebMitotherapeutix is included in 2 Expert Collections, including Cancer. C. Cancer. 4,784 items. Pharmaceutical and biotechnology companies with cancer therapy drug candidates. B. Biopharma Tech. 1,568 items. View All Expert Collections. Mitotherapeutix Patents. Mitotherapeutix has filed 2 patents.
WebMitotherapeutix was created to take advantage of advancements in RNA chemistry and its use in developing siRNA based drugs that can target otherwise difficult to address … Robert Hennessey. Co-Founder & Chairman of Board ... Mitotherapeutix has identified a unique target for its first program. Our first … Mitotherapeutix also has a program focused on Polycystic kidney disease (PKD). … Mitotherapeutix Awarded $2.2 Million SBIR Grant from the National Institutes of … For information contact us at [email protected]. 400 … WebResearch fellow working at biotech company Mitotherapeutix via the UCONN Technology Incubator Program (TIP). The 10-week program …
WebDrug-induced liver injury (DILI) development is commonly associated with acetaminophen (APAP) overdose, where glutathione scavenging leads to mitochondrial dysfunction and hepatocyte death. DILI is a severe disorder without effective late-stage treatment, since N-acetyl cysteine must be administered 8 h after overdose to be efficient. Ammonia … Web4 jun. 2024 · FARMINGTON, Conn. (PR) June 04, 2024 Mitotherapeutix LLC (MITO), a pre-clinical stage company focused on siRNA drug discovery and development based on suppression of the mitochondrial regulator MCJ (DnaJC15), today announced that it has been awarded a multi-year $2.2 million Small Business Innovation Research (SBIR) …
WebMitotherapeutix is a biotechnology drug discovery company focused on cancer and liver disease. Use the CB Insights Platform to explore Mitotherapeutix's full profile. …
WebDescription. Developer of molecules-based drugs designed for the treatment of cancer and degenerative liver disorders. The company's products are used for the treatment of … spartanburg sc to clover scWebAt Mitotherapeutix this definition includes, but is not limited to, the following roles: Principal investigator, co-investigators, research coordinators, research associates, collaborators … spartanburg sc tax recordsWebMitotherapeutix. Advertisement. Global Rank-Daily Visitors-Daily Pageviews-Load Time-Site Overview . The domain Mitotherapeutix.com was registered 3 years ago. The website is currently online. It is ranked n/a in the world . Here are more than n/a visitors and the pages are viewed up to n/a times for every day. spartanburg sc to asheboro ncWebMitotherapeutix is a US-based pre-clinical stage pharmaceutical company that is developing drugs (siRNA) targeting metabolism to treat disease. Our initial program targets a protein MCJ/DNAJC15, found in the mitochondria and is responsible for enhancing the product ion of energy. technicair fresno caWebMitotherapeutix is a US-based pre-clinical stage pharmaceutical company that is developing drugs (siRNA) targeting metabolism to treat disease. Our initial program targets a protein MCJ/DNAJC15, found in the mitochondria and is responsible for enhancing the production of energy. technicair lismoreWebMitotherapeutix develops siRNA-based drugs that focus on addressing difficult disease targets. Mitotherapeutix targets and controls the metabolic activity in the mitochondria helping in the treatment of kidney, immune, and liver diseases. Mitotherapeutix's drug candidates MT-001 to MT004 are in the early stage of the preclinical study. The spartanburg sc to charlotte scWebFarmington, CT – June 3, 2024, Mitotherapeutix LLC (MITO), a pre-clinical stage company focused on siRNA drug discovery and development based on suppression of the mitochondrial regulator MCJ ... technicair ltd